93 related articles for article (PubMed ID: 9138368)
1. [Nationally produced 153SmEDTMP in the palliative treatment of metastatic bone cancer pain].
Olea E; Gil MC; Tomicic M; Araya G; Chandía M; Quintana JC; Pinto L; Orellana P; Nagel J; Ortíz V
Rev Med Chil; 1996 Jul; 124(7):805-12. PubMed ID: 9138368
[TBL] [Abstract][Full Text] [Related]
2. Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
Krishnamurthy GT; Krishnamurthy S
J Nucl Med; 2000 Apr; 41(4):688-91. PubMed ID: 10768570
[No Abstract] [Full Text] [Related]
3. [Analgesic response and secondary effects in patients with osteoblastic metastasis, treated with Samarium 153 ethylenediaminotetramethylenephosphate].
Lovera C; Massardo T; Galleguillos MC; González P; Comparini B; Yáñez M; Fodor M; Gil MC; Araya G; Tomicic M
Rev Med Chil; 1998 Aug; 126(8):963-71. PubMed ID: 9830748
[TBL] [Abstract][Full Text] [Related]
4. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.
Serafini AN; Houston SJ; Resche I; Quick DP; Grund FM; Ell PJ; Bertrand A; Ahmann FR; Orihuela E; Reid RH; Lerski RA; Collier BD; McKillop JH; Purnell GL; Pecking AP; Thomas FD; Harrison KA
J Clin Oncol; 1998 Apr; 16(4):1574-81. PubMed ID: 9552068
[TBL] [Abstract][Full Text] [Related]
5. (153)Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies.
Correa-González L; Arteaga de Murphy C; Pichardo-Romero P; Pedraza-López M; Moreno-García C; Correa-Hernández L
Arch Med Res; 2014 May; 45(4):301-8. PubMed ID: 24681187
[TBL] [Abstract][Full Text] [Related]
6. EANM procedure guidelines for treatment of refractory metastatic bone pain.
Silberstein EB; Taylor AT;
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP7-11. PubMed ID: 12723557
[No Abstract] [Full Text] [Related]
7. [153Sm-EDTMP for moderate and severe bone cancer pain].
Deng H; Luo S; Tan T; Mo T; Liang Z; Pu M; Jiao J; Zhong S; Wang Q; Hu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):391-4. PubMed ID: 8732058
[TBL] [Abstract][Full Text] [Related]
8. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
Serafini AN
Q J Nucl Med; 2001 Mar; 45(1):91-9. PubMed ID: 11456381
[TBL] [Abstract][Full Text] [Related]
9. Samarium-153 lexidronam for painful bone metastases.
Med Lett Drugs Ther; 1997 Aug; 39(1008):83-4. PubMed ID: 9286284
[No Abstract] [Full Text] [Related]
10. [Evaluation of efficacy of 153Sm-EDTMP in patients with painful bone metastases of breast cancer].
Wu H; Tan T; Fang L; Zhang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):716-8. PubMed ID: 14619591
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of repeated samarium-153 lexidronam treatment in a patient with prostate cancer and metastatic bone pain.
Menda Y; Bushnell DL; Williams RD; Miller S; Thomas MO
Clin Nucl Med; 2000 Sep; 25(9):698-700. PubMed ID: 10983757
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study.
Yuan J; Liu C; Liu X; Wang Y; Kuai D; Zhang G; Zaknun JJ
Clin Nucl Med; 2013 Feb; 38(2):88-92. PubMed ID: 23334120
[TBL] [Abstract][Full Text] [Related]
13. Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach.
Bruland OS; Skretting A; Solheim OP; Aas M
Acta Oncol; 1996; 35(3):381-4. PubMed ID: 8679270
[TBL] [Abstract][Full Text] [Related]
14. Advances in our understanding of the treatment of painful bone metastasis.
Siberstein EB
J Nucl Med; 2000 Apr; 41(4):655-7. PubMed ID: 10809605
[No Abstract] [Full Text] [Related]
15. Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.
Sartor O; Reid RH; Bushnell DL; Quick DP; Ell PJ
Cancer; 2007 Feb; 109(3):637-43. PubMed ID: 17167764
[TBL] [Abstract][Full Text] [Related]
16. Samarium-153-lexidronam therapy for metastatic bone pain.
Ribera H
J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):80-1; discussion 81-2. PubMed ID: 23527672
[TBL] [Abstract][Full Text] [Related]
17. New research developments increase therapeutic options for thyroid cancer and bone pain palliation.
Williams JE
J Nucl Med; 1997 Nov; 38(11):19N-20N, 26N. PubMed ID: 9374327
[No Abstract] [Full Text] [Related]
18. Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer.
Farhanghi M; Holmes RA; Volkert WA; Logan KW; Singh A
J Nucl Med; 1992 Aug; 33(8):1451-8. PubMed ID: 1378887
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of painful bony metastases with Samarium 153-EDTMP in prostate carcinoma].
Mhiri A; Hassad R; Sellem A; Bahri H; Diakite R; Slim I; Mahersi M; Hammami H; Ben Adallah M; Ben Slimene MF
Tunis Med; 2007 Jul; 85(7):580-5. PubMed ID: 18064991
[TBL] [Abstract][Full Text] [Related]
20. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
Jiang CY; Zhu BL; Zhang YJ
Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):118-21. PubMed ID: 7523052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
